• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Taro`s Generic PEG-3350 Receives Approval in US

    FDA

    Fresenius Kabi Usa Generic Sodium Chloride Receives Approval in US

    FDA

    B. Braun Launches Levetiracetam in Sodium Chloride Injection Portfolio

    PR NEWSWIRE

    Enforcement Report - Week of February 21, 2024

    FDA

    B. Braun Launches Heparin Sodium 2,000 Units in 0.9% Sodium Chloride Injection

    PR NEWSWIRE

    Enforcement Report - Week of December 13, 2023

    FDA

    Enforcement Report - Week of November 29, 2023

    FDA

    Enforcement Report - Week of November 1, 2023

    FDA

    Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL, Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL, and ELCYS (cysteine hydrochloride Injection), USP 500 mg/10 mL Due to the Presence of Particulate Matter

    FDA

    Enforcement Report - Week of September 6, 2023

    FDA

    Nexus Pharmaceuticals Receives FDA Approval for 0.9% Sodium Chloride Injection

    BUSINESSWIRE

    Nexus` Generic Sodium Chloride Receives Approval in the U.S.

    FDA

    Health Canada Issues Recall of Baxter`s Sodium Chloride Injections

    HEALTH CANADA

    Fresenius` Generic Sodium Chloride Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of June 7, 2023

    FDA

    Enforcement Report - Week of May 31, 2023

    FDA

    Health Canda Issues Recall of Baxter Corporation`s 0.9% Sodium chloride inj; Bags leaking

    HEALTH CANADA

    Health Canada Issues Recall of Baxter`s 0.9% Sodium chloride injection, USP

    HEALTH CANADA

    Long Grove Secures Commercial Rights to an Essential Critical Care Medication

    PR NEWSWIRE

    Enforcement Report - Week of March 1, 2023

    FDA

    Enforcement Report - Week of February 22, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    Enforcement Report - Week of January 11, 2023

    FDA

    Enforcement Report - Week of December 14, 2022

    FDA

    Enforcement Report - Week of October 26, 2022

    FDA

    Enforcement Report - Week of October 5, 2022

    FDA

    Enforcement Report - Week of August 17, 2022

    FDA

    Health Canada Issues Recall of Omega Laboratories`s Sodium Chloride

    HEALTH CANADA

    Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US

    FDA

    Enforcement Report - Week of March 23, 2022

    FDA

    Health Canada Issues recall of Baxter Corporation Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag

    HEALTH CANADA

    B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 250ML

    FDA

    Fresenius Kabi`s Generic Cardioplegic Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of January 5, 2022

    FDA

    Fresenius Kabi`s Generic Testosterone Receives Approval In US

    FDA

    Enforcement Report- Week of June 16, 2021

    FDA

    Enforcement Report - Week of March 31, 2021

    FDA

    Enforcement Report - Week of March 17, 2021

    FDA

    Dr. Reddy`s Announces launch of Dexmedetomidine HCl in 0.9% NaCl Inj. in the US

    BUSINESSWIRE

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi USA`s Generic Dextrose: Sodium Chloride Receives Approval In US

    FDA

    Fresenius Kabi`s Generic Dextrose ; Sodium Chloride Receives Approval in US

    FDA

    CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall

    BUSINESSWIRE

    Enforcement Report - Week of July 1, 2020

    FDA

    Fresenius Kabi`s Recall of Ketorolac Results In QuVa Pharma® Recall of Compounded Sterile Product (R.E.C.K.)

    FDA

    Nephron Pharmac`s Generic Sodium Chloride Receives Approval In US

    FDA

    Enforcement Report - Week of March 25, 2020

    FDA

    Enforcement Report - Week of March 4, 2020

    FDA

    Health Canada Issues Recall of Baxter Corporation`s Dianeal PD4 CAPD

    FDA

    ICU Medical, Inc. Issues a Voluntary Nationwide Recall of Lactated Ringer`s Injection

    FDA

    ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer`s Injection

    FDA

    Enforcement Report - Week of July 31, 2019

    FDA

    Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold by OCuSOFT

    FDA

    Enforcement Report - Week of July 10, 2019

    FDA

    PharMEDium Services, LLC Issues Voluntary Nationwide Recall of 0.5 mg/mL HYDROmorphone HCl in 0.9% Sodium Chloride 1 mL in 3 mL BD Syringe Due to Presence of Sulfite

    FDA

    Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for

    PR NEWSWIRE

    Enforcement Report - Week of April 24, 2019

    FDA

    Enforcement Report - Week of April 17, 2019

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.